Position in AZN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$365,587
-$29,839 QoQ
Shares Held
1,928
-3.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#973
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Souders Financial Advisors holds $13,208,144 across 10 Drug Manufacturers - General names. AZN ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,235 | $5,079,586 | |
| 2 | ABBV |
AbbVie Inc.
|
8,246 | $2,075,023 | |
| 3 | AMGN |
Amgen Inc
|
5,104 | $1,848,260 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,395 | $1,592,757 | |
| 5 | JNJ |
Johnson & Johnson
|
3,322 | $843,688 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,223 | $407,193 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
6,899 | $397,520 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,928 | $365,587 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $365,587 | 1,928 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $395,426 | 2,005 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||